# Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring

> **NCT06469892** · — · COMPLETED · sponsor: **Beijing Stomatological Hospital, Capital Medical University** · enrollment: 225 (actual)

## Conditions studied

- Oral Leukoplakia
- Oral Cancer

## Interventions

- **OTHER:** Detect the expression level of miR-185 in salivary and plasma exosomes.

## Key facts

- **NCT ID:** NCT06469892
- **Lead sponsor:** Beijing Stomatological Hospital, Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-13
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-30
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06469892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06469892, "Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06469892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*